328 related articles for article (PubMed ID: 25380841)
1. A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients.
Heidari B; Fazli MR; Misaeid MA; Heidari P; Hakimi N; Zeraati AA
Clin Exp Nephrol; 2015 Aug; 19(4):725-31. PubMed ID: 25380841
[TBL] [Abstract][Full Text] [Related]
2. The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis.
Musanovic A; Trnacevic S; Mekic M; Musanovic A
Med Arch; 2013; 67(5):361-4. PubMed ID: 24601173
[TBL] [Abstract][Full Text] [Related]
3. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T
PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118
[TBL] [Abstract][Full Text] [Related]
4. The Content of Reticulocyte Hemoglobin and Serum Concentration of the Soluble Transferrin Receptor for Diagnostics of Anemia in Chronically Hemodialyzed Patients.
Kurzawa T; Owczarek A; Strzelczyk JK; Gołąbek K; Wiczkowski A
Adv Clin Exp Med; 2016; 25(3):425-31. PubMed ID: 27629729
[TBL] [Abstract][Full Text] [Related]
5. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.
Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of C-reactive protein in patients on hemodialysis: a longitudinal study.
Teruel JL; Marcen R; Ocaña J; Fernández-Lucas M; Rivera M; Tabernero G; Ortuño J
Nephron Clin Pract; 2005; 100(4):c140-5. PubMed ID: 15855797
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B
Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and iron status in bariatric surgery candidates.
Careaga M; Moizé V; Flores L; Deulofeu R; Andreu A; Vidal J
Surg Obes Relat Dis; 2015; 11(4):906-11. PubMed ID: 25862176
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease.
Ahbap E; Sakaci T; Kara E; Sahutoglu T; Koc Y; Basturk T; Sevinc M; Akgol C; Kayalar AO; Ucar ZA; Bayraktar F; Unsal A
Clin Nephrol; 2016 Apr; 85(4):199-208. PubMed ID: 26521887
[TBL] [Abstract][Full Text] [Related]
10. Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients.
Mahdavi MR; Makhlough A; Kosaryan M; Roshan P
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1158-62. PubMed ID: 22165676
[TBL] [Abstract][Full Text] [Related]
11. Novel inflammatory marker in dialysis patients: YKL-40.
Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
Owen WF; Lowrie EG
Kidney Int; 1998 Aug; 54(2):627-36. PubMed ID: 9690231
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
14. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
15. Iron status biomarkers and C-reactive protein in children aged 19 to 72 months in Chile.
Brito A; Hertrampf E; Olivares M
Food Nutr Bull; 2013 Mar; 34(1):14-20. PubMed ID: 23767277
[TBL] [Abstract][Full Text] [Related]
16. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
17. Linkage of elevated CaxPO4 product with inflammation in maintenance hemodialysis patients.
Nasri H
Minerva Urol Nefrol; 2006 Dec; 58(4):339-45. PubMed ID: 17268399
[TBL] [Abstract][Full Text] [Related]
18. Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients.
Rocha LA; Barreto DV; Barreto FC; Dias CB; Moysés R; Silva MR; Moura LA; Draibe SA; Jorgetti V; Carvalho AB; Canziani ME
Clin J Am Soc Nephrol; 2009 Jan; 4(1):105-9. PubMed ID: 18842949
[TBL] [Abstract][Full Text] [Related]
19. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum C-reactive protein level and its related factors in hemodialysis patients in Sari, Iran.
Baradari AG; Emami Zeydi A; Espahbodi F; Shahmohammadi S
Pak J Biol Sci; 2011 May; 14(10):595-9. PubMed ID: 22097096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
